Alexandria Ocasio-Cortez said...
And while Teva was forced to put pressure, was forced to lower the price in Europe, in that same two-year period, the company raised the price on U.S. multiple sclerosis patients by 60 percent.
Context
Ocasio-Cortez highlights the price increase for U.S. patients while prices dropped in Europe.
09/29/2020